Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1PW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,343
Award facts
- Contract value 100% obligated
- $38,342.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $38,342.50 delivery order to AmerisourceBergen Drug Corp on May 27, 2026, for Dupixent 300 mg/2 ml pen injectable (NSAID therapeutic class), with final delivery due May 28, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open basis across DLA Troop Support Medical and broader DLA procurement lines.
Quick answers
Who was awarded contract SPE2DR26FN1PW?
SPE2DR26FN1PW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2026.
How much is contract SPE2DR26FN1PW worth?
The government has obligated $38,343 on SPE2DR26FN1PW.
Is contract SPE2DR26FN1PW an order under another contract?
Yes. SPE2DR26FN1PW is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FN1PW competed?
The extent of competition for SPE2DR26FN1PW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award